Advertisement
Screener

IRADIMED CORPORATION (IRMD) Increase (Decrease) in Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

IRADIMED CORPORATION Increase (Decrease) in Deferred Revenue

IRADIMED CORPORATION (IRMD) reported Increase (Decrease) in Deferred Revenue of $944.63 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-03-08

  • IRADIMED CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $312.29K, a 32.68% decline year-over-year.
  • IRADIMED CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$151.13K, a 119.57% decline year-over-year.
  • IRADIMED CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $613.44K, a 56.03% increase year-over-year.
  • IRADIMED CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was $170.03K, a 79.59% increase year-over-year.
  • IRADIMED CORPORATION increase (decrease) in deferred revenue for fiscal 2017 was $944.63K, a 45.20% decline from fiscal 2016.
  • IRADIMED CORPORATION increase (decrease) in deferred revenue for fiscal 2016 was $1.72M, a 243.78% increase from fiscal 2015.
  • IRADIMED CORPORATION increase (decrease) in deferred revenue for fiscal 2015 was $501.46K, a 169.35% increase from fiscal 2014.
  • IRADIMED CORPORATION increase (decrease) in deferred revenue for fiscal 2014 was $186.17K.
Period endIncrease (Decrease) in Deferred Revenue 3 monthIncrease (Decrease) in Deferred Revenue 6 monthIncrease (Decrease) in Deferred Revenue 9 monthIncrease (Decrease) in Deferred Revenue 12 month
2017-12-31$312.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$161.17K
derived: sum of 2 quarters · filed 2018-03-08
$774.61K
derived: sum of 3 quarters · filed 2018-03-08
$944.63K
10-K · filed 2018-03-08
2017-09-30-$151.13K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$462.31K
derived: sum of 2 quarters · filed 2017-11-06
$632.34K
10-Q · filed 2017-11-06
$1.10M
derived: sum of 4 quarters · filed 2018-03-08
2017-06-30$613.44K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$783.47K
10-Q · filed 2017-08-04
$1.25M
derived: sum of 3 quarters · filed 2018-03-08
$2.02M
derived: sum of 4 quarters · filed 2018-03-08
2017-03-31$170.03K
10-Q · filed 2017-05-05
$633.95K
derived: sum of 2 quarters · filed 2018-03-08
$1.41M
derived: sum of 3 quarters · filed 2018-03-08
$1.80M
derived: sum of 4 quarters · filed 2018-03-08
2016-12-31$463.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$1.24M
derived: sum of 2 quarters · filed 2018-03-08
$1.63M
derived: sum of 3 quarters · filed 2018-03-08
$1.72M
10-K · filed 2018-03-08
2016-09-30$772.17K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$1.17M
derived: sum of 2 quarters · filed 2017-11-06
$1.26M
10-Q · filed 2017-11-06
$1.41M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$393.15K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$487.83K
10-Q · filed 2017-08-04
$641.85K
derived: sum of 3 quarters · filed 2018-03-08
-$4.27K
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$94.67K
10-Q · filed 2017-05-05
$248.69K
derived: sum of 2 quarters · filed 2018-03-08
-$397.42K
derived: sum of 3 quarters · filed 2018-03-08
$190.17K
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$154.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
-$492.10K
derived: sum of 2 quarters · filed 2018-03-08
$95.50K
derived: sum of 3 quarters · filed 2018-03-08
$501.46K
10-K · filed 2018-03-08
2015-09-30-$646.12K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
-$58.52K
derived: sum of 2 quarters · filed 2016-11-04
$347.44K
10-Q · filed 2016-11-04
$295.25K
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$587.59K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$993.56K
10-Q · filed 2016-08-05
$941.36K
derived: sum of 3 quarters · filed 2017-03-10
$792.05K
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$405.97K
10-Q · filed 2016-05-06
$353.77K
derived: sum of 2 quarters · filed 2017-03-10
$204.46K
derived: sum of 3 quarters · filed 2017-03-10
$609.07K
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31-$52.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
-$201.50K
derived: sum of 2 quarters · filed 2017-03-10
$203.10K
derived: sum of 3 quarters · filed 2017-03-10
$186.17K
10-K · filed 2017-03-10
2014-09-30-$149.31K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
$255.29K
derived: sum of 2 quarters · filed 2015-11-10
$238.37K
10-Q · filed 2015-11-10
$15.08K
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30$404.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11
$387.68K
10-Q · filed 2015-08-11
$164.39K
derived: sum of 3 quarters · filed 2015-08-11
$364.67K
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31-$16.93K
10-Q · filed 2015-05-11
-$240.21K
derived: sum of 2 quarters · filed 2015-05-11
-$39.94K
derived: sum of 3 quarters · filed 2015-05-11
2013-12-31-$223.28K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
-$23.01K
derived: sum of 2 quarters · filed 2015-03-23
-$126.98K
10-K · filed 2015-03-23
2013-09-30$200.27K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$96.30K
10-Q · filed 2014-11-13
2013-06-30-$103.97K
10-Q · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02